It's not a "bad" announcement, IF ANP had a "cleaner historical profile" with investors, it would actually be considered rather good news indeed - of course, viewing it from the perspective, as a positive or a negative the reality is, it's the start of a longer-term journey. But not a "bad" announcement....there is now a real corporate heartbeat.....at least!
Certainly the RNAi space is truly hotting up, so this may yet emerge as a still interesting situation.......
News: ANP Antisense Therapeutics says FDA lifts hold for multiple sclerosis drug study, page-20
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.002(2.04%) |
Mkt cap ! $90.15M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 10.0¢ | $50.98K | 508.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 69109 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 249627 | 5 |
View Market Depth
| Last trade - 16.10pm 20/09/2024 (20 minute delay) ? |
| PER (ASX) Chart |